Cargando…
The use of procalcitonin as an antimicrobial stewardship tool and a predictor of disease severity in coronavirus disease 2019 (COVID-19)
Autores principales: | Drewett, George P., Smibert, Olivia C., Holmes, Natasha E., Trubiano, Jason A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870915/ https://www.ncbi.nlm.nih.gov/pubmed/33487208 http://dx.doi.org/10.1017/ice.2021.28 |
Ejemplares similares
-
COVID-Care – a safe and successful digital self-assessment tool for
outpatients with proven and suspected coronavirus-2019
por: Drewett, George P, et al.
Publicado: (2021) -
Evolution of the Human Cytokine Response from Acute Illness to Disease Resolution in SARS-Cov-2 Infection—Implications for Therapeutic Monitoring and Therapeutic Targets
por: Drewett, George P., et al.
Publicado: (2021) -
The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy—A Prospective Longitudinal Study
por: Copaescu, Ana, et al.
Publicado: (2021) -
The Role of Procalcitonin as an Antimicrobial Stewardship Tool in Patients Hospitalized with Seasonal Influenza
por: Christensen, Ingrid, et al.
Publicado: (2023) -
Asystolic cardiac arrest following liposomal amphotericin B infusion: anaphylaxis or compliment activation-related pseudoallergy?
por: Drewett, George P., et al.
Publicado: (2021)